Su Lu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Cancer-related gene regulation
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
Papers in ⓘ
-
- Ubiquitin and proteasome pathways 6
- Heat shock proteins research 5
- RNA Research and Splicing 4
- Cancer-related gene regulation 4
- Genomics and Chromatin Dynamics 3
- Oncology 11
- Cancer-related Molecular Pathways 4
- Co-authors
- Huamei Tang (15 shared papers)Dongwang Yan (5 shared papers)Zhihai Peng (4 shared papers)Zehua Wu (4 shared papers)Guoqiang Qiu (3 shared papers)Zhihai Peng (9 shared papers)Han Yang (7 shared papers)Chongzhi Zhou (6 shared papers)
- Journals
- Oncology Reports (3 papers)Journal of Experimental & Clinical Cancer Research (3 papers)Medical Oncology (2 papers)SLAS DISCOVERY (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Su Lu
30 papers receiving 786 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 337
- Molecular Biology 537
- Oncology 158
- Immunology 90
- Pathology and Forensic Medicine 72
Countries citing papers authored by Su Lu
This map shows the geographic impact of Su Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su Lu more than expected).
Fields of papers citing papers by Su Lu
This network shows the impact of papers produced by Su Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su Lu. The network helps show where Su Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Su Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 187 | |
| 2 | 2016 | 59 | |
| 3 | 2018 | 56 | |
| 4 | 2013 | 45 | |
| 5 | 2019 | 37 | |
| 6 | 2013 | 35 | |
| 7 | 2018 | 35 | |
| 8 | 2013 | 34 | |
| 9 | 2015 | 33 | |
| 10 | 2015 | 30 | |
| 11 | 2009 | 28 | |
| 12 | Increased expression of prothymosin-α, independently or combined with TP53, correlates with poor prognosis in colorectal cancer. | 2014 | 24 |
| 13 | 2016 | 23 | |
| 14 | 2014 | 22 | |
| 15 | 2014 | 21 | |
| 16 | SERPINA4 is a novel independent prognostic indicator and a potential therapeutic target for colorectal cancer. | 2016 | 19 |
| 17 | 2014 | 18 | |
| 18 | 2014 | 15 | |
| 19 | 2021 | 14 | |
| 20 | 2015 | 14 |
About Su Lu
Su Lu is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Cancer Research and Immunology, having authored 32 papers that have together received 794 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (6 papers), Heat shock proteins research (5 papers), Genetic factors in colorectal cancer (4 papers), RNA Research and Splicing (4 papers), Cancer-related Molecular Pathways (4 papers), Cancer-related gene regulation (4 papers), Genomics and Chromatin Dynamics (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Cancer Research (337 citations), Molecular Biology (537 citations), Oncology (158 citations), Immunology (90 citations) and Pathology and Forensic Medicine (72 citations). Su Lu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Huamei Tang, Dongwang Yan, Zhihai Peng, Zehua Wu, Guoqiang Qiu, Zhihai Peng, Han Yang, Chongzhi Zhou, Tao Jiang and Xiaoliang Wang. Their work appears in journals such as Oncology Reports, Journal of Experimental & Clinical Cancer Research, Medical Oncology, SLAS DISCOVERY and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.